Cargando…
The loss of B7-H4 expression in breast cancer cells escaping from T cell cytotoxicity contributes to epithelial-to-mesenchymal transition
BACKGROUND: B7 homology 4 (B7-H4), a potential target for cancer therapy, has been demonstrated to inhibit T cell cytotoxicity in the early stages of breast cancer. However, B7-H4 manipulating breast tumor immune microenvironment (TIME) in the tumor progression remains unknown. METHODS: We engineere...
Autores principales: | Zhou, Linlin, Wu, Jichun, Ruan, Mei, Xiao, Yonglei, Lan, Hailin, Wu, Qiongwen, Yu, Chen-Wei, Zhang, Qiuyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548745/ https://www.ncbi.nlm.nih.gov/pubmed/37794509 http://dx.doi.org/10.1186/s13058-023-01721-5 |
Ejemplares similares
-
Epithelial-mesenchymal transition as strategic microenvironment mimicry for cancer cell survival and immune escape?
por: Qin, Jun-Hui, et al.
Publicado: (2016) -
SIRT1 upregulation promotes epithelial-mesenchymal transition by inducing senescence escape in endometriosis
por: Wang, Minghua, et al.
Publicado: (2022) -
Epithelial–Mesenchymal Transition Contributes to Docetaxel Resistance in Human Non-Small Cell Lung Cancer
por: Shen, Weiwei, et al.
Publicado: (2014) -
Loss of GFAT1 promotes epithelial-to-mesenchymal transition and predicts unfavorable prognosis in gastric cancer
por: Duan, Fangfang, et al.
Publicado: (2016) -
Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition
por: Gorges, Tobias M, et al.
Publicado: (2012)